Royal Philips, a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Philips BlueControl wearable light therapy device to treat mild psoriasis. In the U.S., BlueControl is a Class II prescription medical device designed for home use. Reducing the symptoms of…